Evaluation of a new left ventricular assist device as a bridge to cardiac transplantation

The Department of Cardiovascular-Thoracic Surgery is participating in a study of a new third-generation left ventricular assist device in patients with end-stage chronic heart failure who require circulatory support as a bridge to cardiac transplant.

You may be eligible to participate in this study if you are eligible for a heart transplant, meet the requirements for circulatory support until transplantation, are willing and able to give informed consent.

This is a partial list of eligibility and exclusion criteria. For more information, call the contact number provided. If you wish to inquire via e-mail, please refer to the study title in your message.